effects [qlco]
High dose [qnco]
estrogen therapy [topp]
Circulating [ftcn]
Inflammatory [ftcn]
Marker [clna]
Introduction [hlca]
Initial [tmco]
Study [mnob]
Suggest [idcn]
HRT [topp]
Reduced [qlco]
coronary heart disease [dsyn]
Suggest [idcn]
HRT [topp]
CARDIOVASCULAR [bdsy]
ROUTE [ftcn]
HRT [topp]
Administration [ocac]
APPEAR [qlco]
Oral [spco]
estrogen increasing [fndg]
Levels [qlco]
Inflammatory [ftcn]
Marker [clna]
transdermal estrogen [horm, phsu, strd]
Causing [ftcn]
effects [qlco]
Very high [fndg]
Levels [qlco]
Estrogen [horm, phsu, strd]
Taken [cnce]
Male-to-female transsexual [fndg]
Poorly [qlco]
Understand [menp]
Study [mnob]
Compared [acty]
Circulating [ftcn]
Inflammatory [ftcn]
Marker [clna]
Following [tmco]
months [tmco]
Oral [spco]
transdermal estrogen [horm, phsu, strd]
therapy [ftcn]
Materials [sbst]
Methods [inpr]
Patients [podg]
Age-Years [tmco]
Commence [acty]
Oral [spco]
Estrogen [horm, phsu, strd]
Group 1 [inpr]
Group 2 [inpr]
Patients [podg]
Age-Years [tmco]
Commence [acty]
transdermal estrogen [horm, phsu, strd]
Plasma lipids [lbpr]
Total Cholesterol [lbpr]
Triglyceride [bacs, lipd]
Cholesterol, HDL [bacs, lipd]
Cytokines [aapp, imft]
IL1 [aapp, imft]
IL6 [aapp, imft]
IL 8 [aapp, imft]
tnf alpha [aapp, imft]
Antioxidants [phsu]
Superoxide Dismutase [aapp, enzy, phsu]
Nitric Oxide [bacs, inch, phsu]
Glutathione [aapp, bacs]
Clotting factors [aapp, bacs, phsu]
Fibrinogen [aapp, bacs, phsu]
Measured [qlco]
months [tmco]
treatment [ftcn]
plasma lipid [lbpr]
Group 1 [inpr]
Patients [podg]
Raised [qnco]
IL6 [aapp, imft]
IL1 [aapp, imft]
IL 8 [aapp, imft]
months [tmco]
treatment [ftcn]
Levels [qlco]
Fall [fndg]
Levels [qlco]
Group I [inpr]
Increased [qnco]
Study [mnob]
Patients [podg]
Receive [qlco]
transdermal estrogen [horm, phsu, strd]
Elevated [qlco]
Levels [qlco]
GSH [aapp, bacs]
Second [qnco]
treatment [ftcn]
Parameters [fndg]
Measured [qlco]
Levels [qlco]
IL1 [aapp, imft]
Factor IX [aapp, bacs, phsu]
Second [qnco]
treatment [ftcn]
Oral [spco]
Group [idcn]
Transdermal [ftcn]
Group [idcn]
treatment [ftcn]
Group [idcn]
Transsexual [fndg]
Patients [podg]
Receive [qlco]
Oral [spco]
Estrogen [horm, phsu, strd]
Inflammatory [ftcn]
markets [geoa]
pathogenesis [ftcn]
Vascular disease [dsyn]
transdermal estrogen [horm, phsu, strd]
Inflammatory [ftcn]
Marker [clna]
Patients [podg]
Receive [qlco]
transdermal estrogen [horm, phsu, strd]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
